Files

Download

Download Full Text (623 KB)

Publication Date

5-2022

Abstract

Background: The delta variant of SARS-CoV-2 is reported to cause severe acute lung injury (ALI) in neonates. Neonates with COVID-19 can exhibit a hyper-inflammatory response with vascular injury. The mechanisms by which SARS-CoV-2 structural proteins induce ALI in neonates is unclear. Emerging data suggest that the envelope (E protein) of the SARS-CoV-2 activates Toll Like Receptor (TLR)-mediated immune hyperactivation and cytokine storm. We tested the hypothesis that SARS-CoV-2 E protein can induce TLR-mediated inflammation and ALI in a neonatal mouse model of ALI we developed.

Objectives: 1) To investigate the pathogenicity of E protein in causing neonatal ALI and alveolar remodeling and, 2) To determine whether E protein induces TLR-dependent cell death and inflammation in human pulmonary microvascular endothelial cells (HPMEC).

Methods: We developed a model of systemic E protein-induced ALI using intraperitoneal injections of 10μg (2mg/kg/dose) in P5 [saccular stage] C57BL6 mice. Lung homogenates were used for quantifying cytokine RNA expression and TLR signaling (immunoblotting) 48h after E protein injections. Bronchoalveolar lavage (BAL) was done on P11 mice 48h after i.p E protein. E protein-induced alveolar remodeling was examined by morphometry on P14 after injecting one dose (P5) or two i.p doses (P5 and P8). Neonatal HPMEC (ScienCell) were treated with 500ng/mL E protein, with or without silencing of TLR2 (siTLR2), and cell lysates were examined for cytokine expression and TLR signaling.

Results: E protein induced lung Cxcl1, iNOS, Il-1β, and Tnfαexpression in a dose-dependent manner at 48h. Activation of TLR signaling was evidenced by phosphorylation of inhibitor of kappa B kinase β (pIKKβ) and the NFKB subunit p65 (Fig.1). BAL showed increased albumin content and neutrophil and lymphocyte infiltration 48h after i.p E protein. E protein-induced alveolar simplification was evidenced by decreased radial alveolar counts on P14. (Fig. 2). E protein dose-dependently induced HPMEC cell death [Fig. 3a], as well as TLR signaling [p-IKKβ], NFKB activation [p-p65], and MAPK signaling [p-p38] in HPMEC. E protein (500ng/ml) induced ICAM1, IL-1β, TNFα, IL6, IL8, and TLR2 expression was suppressed by silencing TLR2 using siRNA. (Fig. 3)

Conclusion: The SARS-CoV-2 E protein induces TLR signaling, ALI and alveolar remodeling in the neonatal lung. Ongoing studies suggest that E protein induces direct EC injury in human lung EC that is TLR2-dependent. This study provides mechanistic insight into neonatal immune activation and lung injury seen in infants with COVID-19.

Document Type

Poster

The Sars-Cov-2 E Protein Induces Pro-Inflammatory Tlr Signaling, Lung Injury And Alveolar Remodeling In The Neonatal Lung

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.